The Venus Times

CDSCO’s new labelling reforms mark a smart step toward safer medicines, clearer packaging, and stronger global trust in Indian pharma. This feature highlights its importance

We are proud to share that Venus Remedies received new marketing authorizations, including a significant regulatory accomplishment in Indonesia for its antibiotic combination, Ceftazidime + Avibactam. This marks Venus Remedies’ entry in the anti-infective segment in Indonesia, and the product will become the first generic version of Ceftazidime + Avibactam launched. It

The new year started with a grand Officers & Management Meet at Venus Remedies. Our esteemed leadership and the HODs came together to reflect on the achievements of 2025, set goals for 2026, and celebrate the winners of the KBC 2025 championship. The event was made extra special by the

The New Year at Venus Remedies was welcomed with a sense of optimism, reflection, and shared purpose. As teams across the organisation came together to mark the first day of the year, the focus remained on setting the right tone for the months ahead. The occasion was not just about

2025 was a year of steady progress at Venus Remedies—shaped by collaboration, responsibility, and a continued focus on quality across teams and locations. From global platforms to internal initiatives and community programs, the year reflected how progress is built through people working together with purpose. Recognition That Motivated Us